RECRUITING

Heat, Microvascular Function and Aging

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Vascular dysfunction is a common factor in many chronic debilitating diseases, contributing to morbidity and mortality. With the onset of chronic disease or exposure to stress, the vasculature displays an inability to adequately respond to increased blood flow demands, manifesting in a reduced ability or altered mechanism of vasodilation. Aging is an independent risk factor in the development of cardiovascular disease, and reduces vasodilator capacity, or alters the mechanism by which vasodilation occurs in multiple vascular beds. Chronic exercise/physical activity is one of the most potent ways to enhance vascular function, resulting in favorable outcomes such as reductions in blood pressure, and improved ability to perform activities of daily living. Barriers to exercise or failure of long-term adherence preclude many populations from the cardiovascular benefits of exercise, thus further enhancing cardiovascular risk. Avenues to mimic blood flow patterns observed with exercise may exert beneficial effects without the need for the ability to exercise. Recent evidence has demonstrated that passive heat therapy, or chronic heat exposure (\~ +1°C in core temperature) results in reductions in major adverse cardiovascular events, blood pressure and improved large artery endothelial function, primarily through preservation of large artery function in response to vascular stress. It is unclear whether microvascular function is augmented in response to acute heat exposure, or whether this can protect against vascular insults particularly in older adults. Some preliminary evidence in humans suggest that autophagy, a cell recycling process is involved in the beneficial cardiovascular effects, as short-term heat exposure upregulates markers of autophagy. Previous evidence from our lab indicates that autophagy governs the mechanism by which microvascular vasodilation occurs. The role of autophagy in mediating the beneficial effects of passive heating is unknown.

Official Title

Heat, Microvascular Function and Aging

Quick Facts

Study Start:2025-05-01
Study Completion:2028-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06633198

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants must be between 18-80 yrs. of age
  2. * No more than 1 cardiovascular risk factor (see list in exclusion criteria)
  1. * Cardiovascular Risk Factors
  2. * Uncontrolled/unmanaged hypertension and/or use of current anti-hypertensive therapy
  3. * Current Tobacco product use or within last 6 months
  4. * BMI greater than 30
  5. * Hyperlipidemia - diagnosed and/or taking medications to manage
  6. * Hypercholesterolemia - diagnosed and/or taking medications to manage (e.g. statins)
  7. * Type 1 or Type 2 Diabetes
  8. * Use of anti-coagulant or anti-platelet drugs
  9. * Use of beta blockers
  10. * Symptomatic coronary artery disease
  11. * Diagnosed Heart Failure (Any classification above Class I as defined by NY Heart Association)
  12. * Diagnosed renal impairment Renal impairment defined, according to National Kidney Foundation as abnormalities of kidney structure or function, present for greater than 3 months, including:
  13. * Albuminuria (ACR ≥ 30 mg/g)
  14. * Urine sediment abnormalities
  15. * Electrolyte and other abnormalities due to tubular disorders
  16. * Structural abnormalities detected by imaging
  17. * History of kidney transplantation
  18. * Decreased glomerular filtration rate (GFP \< 60 mL/min/1.73 m2)
  19. * Current Hormone Replacement Therapy Use
  20. * History of retinopathy
  21. * Documented neuromuscular disorders
  22. * Porphyria Cutanea Tarda (blistering of skin to sun; photosensitivity)
  23. * Pregnancy (Young Female subjects)
  24. * Allergies to povidone iodine
  25. * Tattoos on lower arm (forearm)
  26. * Use of erectile dysfunction medication in the past 6 months
  27. * Use of topical/non-topical steroids in last 6 months (e.g. cortisone cream)
  28. * Active anti-cancer treatment or treatment within last 12 months
  29. * Active COVID-19 or within the past 3 months
  30. * Gender Reassignment Therapy

Contacts and Locations

Study Contact

William E Hughes, Ph.D.
CONTACT
414-955-7519
whughes@mcw.edu

Study Locations (Sites)

Medical College of Wisconsin
Milwaukee, Wisconsin, 53226
United States

Collaborators and Investigators

Sponsor: William Hughes

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-01
Study Completion Date2028-12-31

Study Record Updates

Study Start Date2025-05-01
Study Completion Date2028-12-31

Terms related to this study

Keywords Provided by Researchers

  • Passive heating
  • Aging
  • Microvascular
  • Autophagy

Additional Relevant MeSH Terms

  • Aging